Sanofi Cash Flows From Used In Operations Before Changes In Working Capital
Sanofi (SNYNF) reported Cash Flows From Used In Operations Before Changes In Working Capital of EUR 8.77 billion for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-17.
Financial Statements › Notes
ifrs-full:CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital · last filed 2026-02-17
| Period end | Cash Flows From Used In Operations Before Changes In Working Capital 6 month | Cash Flows From Used In Operations Before Changes In Working Capital 6 month as first filed | Cash Flows From Used In Operations Before Changes In Working Capital 12 month | Cash Flows From Used In Operations Before Changes In Working Capital 12 month as first filed |
|---|---|---|---|---|
| 2025-12-31 | 8.77B EUR 20-F · filed 2026-02-17 | |||
| 2025-06-30 | 3.98B EUR 6-K · filed 2025-10-27 | |||
| 2024-12-31 | 9.22B EUR 20-F · filed 2026-02-17 | |||
| 2024-06-30 | 3.61B EUR 6-K · filed 2025-10-27 | 4.06B EUR 6-K · filed 2024-07-25 | ||
| 2023-12-31 | 8.86B EUR 20-F · filed 2026-02-17 | 9.49B EUR 20-F · filed 2024-02-23 | ||
| 2023-06-30 | 4.38B EUR 6-K · filed 2024-07-25 | |||
| 2022-12-31 | 10.43B EUR 20-F · filed 2025-02-13 | 11.23B EUR 20-F · filed 2023-02-24 | ||
| 2022-06-30 | 4.87B EUR 6-K · filed 2023-07-28 | |||
| 2021-12-31 | 9.11B EUR 20-F · filed 2024-02-23 | |||
| 2021-06-30 | 4.19B EUR 6-K · filed 2022-07-28 | 4.22B EUR 6-K · filed 2021-07-29 | ||
| 2020-12-31 | 7.74B EUR 20-F · filed 2023-02-24 | 7.77B EUR 20-F · filed 2021-03-04 | ||
| 2020-06-30 | 4.32B EUR 6-K · filed 2021-07-29 | |||
| 2019-12-31 | 8.13B EUR 20-F · filed 2022-02-23 | 8.16B EUR 20-F · filed 2020-03-05 | ||
| 2019-06-30 | 3.98B EUR 6-K · filed 2020-07-29 | |||
| 2018-12-31 | 6.83B EUR 20-F · filed 2021-03-04 | |||
| 2017-12-31 | 7.23B EUR 20-F · filed 2020-03-05 | 7.23B EUR 20-F/A · filed 2018-03-16 | ||
| 2016-12-31 | 7.01B EUR 20-F · filed 2019-03-08 | 7.01B EUR 20-F/A · filed 2018-03-16 | ||
| 2015-12-31 | 7.24B EUR 20-F/A · filed 2018-03-16 |